Trading

Nicolab

Connecting Human & Artificial Intelligence to Revolutionise Emergency Care

Trade Now

Connecting Human & Artificial Intelligence to Revolutionise Emergency Care

x

INDUSTRY

Medical

STATUS

trading

OPEN TO

public

Investment Highlights


  • Ground-breaking technology enabling fast & accurate brain image analysis

  • StrokeViewer®: The world’s first stroke technology certified for diagnostic use

  • Milestone reached processing brain scans of over 25,000 unique suspected stroke patients

  • Strategic Partnership with technology leader Philips to deliver a combined product offering

Company Overview


  • Ground-Breaking Technology

  • Global Solution

  • Connecting Human & Artificial Intelligence

    Set to revolutionise Emergency Care

  • Focus on commercial roll-out in target markets

    Key focus on Australia, US, and the Netherlands

NICO.LAB have launched StrokeViewer®, the world’s first stroke technology certified for diagnostic use.

StrokeViewer consists of a comprehensive set of tools to support the entire stroke workflow that saves critical time in stroke care, connects teams and identifies more anomalies for closer inspection.

Built by leading University medical researchers

NICO.LAB was founded in 2015 as a spin-off from the Amsterdam University Medical Centre in the Netherlands and has offices in Australia, Europe and the United States.

An international team of researchers, developers and physicians connects human & artificial intelligence to empower physicians in emergency care with end-to-end solutions.

Local availability of StrokeViewer functionality is subject to applicable CE marking, TGA and FDA approval

slide-image

Previous Funding

September 30, 2022 – Philips makes a strategic investment of A$6.45M at a price of A$1.00

June 30, 2021 – Nicolab raises A$13M in pre-IPO investment round.

Key Investors

Philips has invested A$6.45M in Nicolab as a strategic partner including a shared product roadmap for a new combined offering

Philips is market leader in Image Guided Therapy, offering Nicolab a unique position to capitalise on its strength in the market

Team


  • Management
  • Directors
  • Merel Boers, PhD

    Chief Executive Officer, Director & Co Founder

    iconicon
  • Renan Sales Barros

    Chief Technology Officer & Co Founder

    iconicon
  • Paul J. Lappin

    Non Executive Chairman

    iconicon
  • Paul Guerra

    Non Executive Director

    iconicon
  • Bronwyn King AO, MD

    Non Executive Director

    iconicon
  • Nico Klay, MD, MBA

    Non Executive Director

    iconicon

News


  • October 2022

    Nicolab at World Stroke Congress 2022
    Read more
  • September 2022

    Nicolab and GNI announce a new collaboration
    Read more
  • July 2022

    Nicolab enters new partnership with Philips
    Read more
  • May 2022

    RAD-x and Nicolab announce research collaboration
    Read more

Ask us a question

Ask Us a Question

Already a member?

Login now

Become a member

Register now

    Thank you for your enquiry.
    We will be in touch as soon as possible.